{"organizations": [], "uuid": "d0de2d10b356cce8ac7f884558369942814a7a42", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180110.html", "section_title": "Archive News &amp; Video for Wednesday, 10 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/buzz-biomerica-chinas-fda-approves-color/buzz-biomerica-chinas-fda-approves-colorectal-screening-test-for-cancer-idUSL4N1P5429", "country": "US", "domain_rank": 408, "title": "BUZZ-Biomerica: China's FDA approves colorectal screening test for cancer", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.014, "site_type": "news", "published": "2018-01-10T23:29:00.000+02:00", "replies_count": 0, "uuid": "d0de2d10b356cce8ac7f884558369942814a7a42"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/buzz-biomerica-chinas-fda-approves-color/buzz-biomerica-chinas-fda-approves-colorectal-screening-test-for-cancer-idUSL4N1P5429", "ord_in_thread": 0, "title": "BUZZ-Biomerica: China's FDA approves colorectal screening test for cancer", "locations": [], "entities": {"persons": [{"name": "bernard orr", "sentiment": "none"}, {"name": "akankshita mukhopadhyay", "sentiment": "none"}], "locations": [{"name": "china", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "** Diagnostic test maker’s shares up as much as 64.77 pct to touch record high of $7.25 - biggest intraday pct gain since May 2016\n** Stock second biggest gainer on Nasdaq\n** Says China’s Food and Drug Administration approved colorectal screening test to help identify the early warning signs of colorectal cancer, also known as bowel cancer\n** About 376,000 new cases of colorectal cancer were reported annually in China and about 191,000 die from the disease every year, the company said\n** More than 376,000 shares traded, 17.8x 30-day moving avg\n** Up to Tuesday’s close, stock had risen 79.6 pct in the past twelve months (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Bernard Orr)\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-10T23:29:00.000+02:00", "crawled": "2018-01-11T12:38:18.021+02:00", "highlightTitle": ""}